Back to BlackRock, Inc.

LGND
6 quarters

Position history for BlackRock, Inc.'s holdings in LIGAND PHARMACEUTICALS INC

BlackRock, Inc. holds 3M shares of LGND (LIGAND PHARMACEUTICALS INC), worth $591.3M as of 2026-Q1. The position was increased (+0.7% shares). LGND represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$591.3M

Current Shares

3M

Total Value Change

+$275.7M

Total Shares Change

+15,839

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
3M
+0.7%
$591.3M0.0%$204.24
32
2025-Q4
Increased
2.9M
+1.9%
$555.9M0.0%$190.20
32
2025-Q3
Decreased
2.9M
-1.0%
$511M0.0%$173.13
0
2025-Q2
Decreased
2.9M
-0.2%
$331.2M0.0%$114.15
0
2025-Q1
Decreased
2.9M
-0.9%
$307M0.0%$107.62
0
2024-Q4
New
2.9M
-
$315.7M0.0%$105.76
43

Other major holders of LGND: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used